Arcadia Biosciences, Inc. (RKDA) is a publicly traded Basic Materials sector company. As of November 12, 2026, RKDA trades at $0.30 with a market cap of $1.03M and a P/E ratio of -0.07. RKDA moved -7.75% today. Year to date, RKDA is -85.30%; over the trailing twelve months it is -91.25%. Its 52-week range spans $0.28 to $6.71. Rallies surfaces RKDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $0.30 |
| Market Cap | $1.03M |
| P/E Ratio | -0.07 |
| EPS | $-4.54 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.71 |
| 52-Week Low | $0.28 |
| Volume | 680.13K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.75M |
| Net Income | $-11.09M |
| Gross Margin | 34.58% |
RKDA analyst coverage data. Average price target: $0.00.